According to Nektar Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 190,406,000. At the end of 2023 the company had 190,406,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.19 B | 1.15% |
2022 | 0.18 B | 1.77% |
2021 | 0.18 B | 2.94% |
2020 | 0.17 B | 2.02% |
2019 | 0.17 B | 1.65% |
2018 | 0.17 B | 9.44% |
2017 | 0.15 B | 6.21% |
2016 | 0.14 B | 11.11% |
2015 | 0.13 B | 3.74% |
2014 | 0.12 B | 11.25% |
2013 | 0.11 B | 0.94% |
2012 | 0.11 B | 0.67% |
2011 | 0.11 B | 21.44% |
2010 | 94.21 M | 1.53% |
2009 | 92.78 M | 0.39% |
2008 | 92.42 M | 0.43% |
2007 | 92.02 M | 2.23% |
2006 | 90.01 M | 4.39% |
2005 | 86.22 M | 2.83% |
2004 | 83.85 M | 50.17% |
2003 | 55.83 M | 0.94% |
2002 | 55.31 M | 0.86% |
2001 | 54.84 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 1,164.25% | ๐บ๐ธ USA |
Pfizer PFE | 5,647,000,000 | 2,865.77% | ๐บ๐ธ USA |
Amgen AMGN | 535,000,000 | 180.98% | ๐บ๐ธ USA |
Baxter BAX | 507,000,000 | 166.27% | ๐บ๐ธ USA |
Merck MRK | 2,554,166,667 | 1,241.43% | ๐บ๐ธ USA |
AstraZeneca AZN | 3,098,000,000 | 1,527.05% | ๐ฌ๐ง UK |
Richardson Electronics RELL | 14,279,000 | -92.50% | ๐บ๐ธ USA |
Alkermes ALKS | 166,607,000 | -12.50% | ๐ฎ๐ช Ireland |